1 - 6 of 6 results
lady sitting on floor silhouette
0.5 CME CREDIT

Managing MDD With an Incomplete Treatment Response

An Interactive, Branching Patient Case

0.50 CME/MOC
0.50 AANP | 0.25 Pharmacology

Individuals with major depressive disorder (MDD) experiencing an incomplete response to initial antidepressant monotherapy can suffer functional impairment and poor clinical outcomes. The interactive, branching activity provides you with an opportunity to assess such a patient and make management decisions over multiple visits in a primary care setting. By the end of this complex case, you will be better equipped to recognize when a patient would benefit from treatment advancement and will understand the patient and pharmacologic factors involved in individualizing treatment escalation, including how and when to employ combination antidepressant therapy or augmentation with a second-generation antipsychotic agent.


Young lady holding her face down, really upset
0.5 CME CREDIT

MDD With a Partial Treatment Response—Candidates for Treatment Escalation (Module 1)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.46 AANP

This video-based resource activity will feature a dialogue between two expert faculty on the health, psychosocial, and functional burden of MDD on patients who experience an incomplete response to treatment. The discussion will emphasize the importance of prompt recognition of these individuals so that therapy advancement can occur at the earliest opportunity and will provide practical tools to help PCPs make this identification.


Upset young man looking outside window with hand against window
0.5 CME CREDIT

What PCPs Should Know About Adjunctive Therapy for MDD (Module 3)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.32 Pharmacology

This video-based resource activity is designed to provide an overview of adjunctive therapy to treat patients with MDD who are experiencing a partial treatment response. These therapies include second-generation antipsychotic agents, esketamine, and non-pharmacologic modalities. Expert faculty will discuss the neurochemical rationale behind adjunctive treatment and differentiate between the various pharmacologic agents, with an emphasis on efficacy, adverse effects, and clinical profiles that can guide their use.


Upset young lady looking outside window on a rainy day
0.5 CME CREDIT

Advancing Antidepressant Therapy for Patients with MDD Who Have an Inadequate Treatment Response (Module 2)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.25 Pharmacology

In this video-based resource activity, expert faculty will discuss options for advancing antidepressant therapy in patients with an incomplete response to antidepressant monotherapy, including the neurochemical rationale for combining antidepressant therapy. It will also provide an approach for selecting antidepressant therapy in which the drugs’ clinical profiles correspond best to individual patient’s symptoms and other clinical factors.


frankly speaking cme 278
0.25 CME CREDIT

Forget About Weed - Frankly Speaking EP 278

Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

0.25 CME

Misconceptions abound on the long-term effects of chronic use of marijuana. This episode tackles these misconceptions head-on, highlighting new data on marijuana’s adverse effects on central nervous system function, including loss of memory, IQ points, and executive functioning. It’s a must-listen for clinicians caring for patients engaging in regular marijuana use.